marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Sangamo Therapeutics Financial Ratios 2011-2024 | SGMO
Annual Financial Ratios Sangamo Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.6 | -6.1 | -15.2 | -8.5 | -16.4 | -30.0 | -3.5 | -10.4 | -32.4 | -41.9 | -22.6 | -4.7 |
P/S |
0.8 | 1.1 | 9.8 | 15.5 | 7.9 | 13.3 | 44.7 | 12.9 | 10.7 | 18.7 | 46.2 | 23.2 | 16.2 |
EPS |
-1.5 | -1.2 | -1.2 | -0.9 | -0.8 | -0.7 | -0.7 | -1.0 | -0.6 | -0.4 | -0.5 | -0.4 | -0.7 |
EV (Enterprise Value) |
175 M | 289 M | 1.25 B | 2.15 B | 934 M | 1.21 B | 1.68 B | 250 M | 377 M | 888 M | 1.12 B | 499 M | 157 M |
EBITDA per Share |
-1.48 | -1.23 | -1.2 | -0.864 | -0.852 | -0.772 | -0.703 | -1.01 | -0.658 | -0.388 | -0.466 | -0.408 | -0.696 |
EV/EBITDA |
-6.8 | -14.7 | -7.6 | -13.1 | -28.9 | -3.2 | -7.7 | -32.7 | -42.3 | -22.4 | -4.3 | ||
PEG |
-0.04 | -0.05 | -1.02 | 0.56 | 0.4 | 16.75 | -0.96 | 0.05 | 0.21 | -1.73 | 2.93 | -0.55 | 0.16 |
P/B |
1.7 | 0.4 | 2.9 | 3.7 | 1.9 | 3.1 | 8.7 | 1.8 | 2.2 | 4.1 | 9.2 | 7.8 | 2.1 |
P/CF |
-0.6 | -0.5 | -4.6 | 11.8 | -4.9 | -190.0 | 220.2 | -3.8 | -11.7 | -136.2 | -56.0 | -57.1 | -6.3 |
ROE % |
-311.06 | -65.19 | -47.50 | -24.28 | -22.01 | -18.64 | -29.04 | -52.61 | -21.15 | -12.78 | -21.87 | -34.31 | -44.61 |
ROA % |
-155.96 | -34.18 | -24.70 | -12.89 | -14.93 | -11.57 | -19.03 | -45.38 | -18.74 | -10.86 | -18.90 | -26.98 | -40.93 |
ROCE % |
-330.58 | -68.24 | -48.85 | -16.30 | -18.53 | -15.07 | -23.30 | -50.18 | -23.77 | -11.94 | -20.39 | -30.10 | -44.70 |
Current Ratio |
2.0 | 2.1 | 2.1 | 4.6 | 5.8 | 5.2 | 5.5 | 11.3 | 10.6 | 9.1 | 9.6 | 7.8 | 11.9 |
DSO |
4.8 | 15.9 | 18.5 | 19.3 | 134.0 | 21.8 | 35.8 | 97.8 | 26.1 | 85.9 | 52.8 | 72.8 | 44.2 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
4.8 | 15.9 | 18.5 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
4.8 | 15.9 | 18.5 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sangamo Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.05 | -0.18 | -0.59 | -0.66 | 0.13 | - | -0.34 | -0.29 | -0.3 | - | -0.33 | -0.33 | -0.32 | -0.29 | -0.01 | -0.26 | -0.37 | 0.04 | -0.24 | -0.26 | -0.41 | -0.18 | -0.13 | -0.17 | -0.23 | -0.15 | -0.15 | -0.17 | -0.23 | -0.14 | -0.27 | -0.38 | -0.23 | -0.2 | -0.13 | -0.17 | -0.08 | -0.06 | -0.11 | -0.1 | -0.12 | -0.13 | -0.11 | -0.1 | -0.13 | -0.07 | -0.11 | -0.11 | -0.14 | -0.12 | -0.18 | -0.2 | -0.21 |
EBITDA per Share |
- | - | - | - | 0.13 | - | -0.29 | -0.31 | -0.29 | - | -0.29 | -0.34 | -0.31 | - | - | -0.25 | -0.37 | - | -0.23 | -0.28 | -0.42 | - | -0.14 | -0.18 | -0.24 | - | -0.14 | -0.17 | -0.23 | - | -0.26 | -0.37 | -0.23 | - | -0.17 | -0.17 | -0.09 | - | -0.11 | -0.1 | -0.12 | - | -0.1 | -0.1 | -0.13 | - | -0.1 | -0.1 | -0.14 | - | -0.17 | -0.19 | -0.18 |
ROE % |
-251.44 | -272.42 | -137.11 | -77.10 | -41.65 | -43.90 | -55.65 | -50.20 | -47.23 | -32.10 | -40.25 | -28.82 | -25.44 | -24.28 | -15.08 | -21.08 | -20.87 | -22.01 | -28.15 | -25.34 | -22.88 | -18.64 | -20.52 | -23.59 | -25.70 | -29.04 | -29.14 | -36.49 | -49.36 | -52.61 | -52.83 | -43.71 | -30.50 | -21.15 | -15.96 | -14.81 | -11.88 | -12.78 | -17.39 | -18.78 | -19.88 | -21.87 | -20.54 | -24.42 | -28.76 | -34.31 | -36.88 | -39.88 | -43.86 | -44.61 | -11.92 | -12.80 | -11.95 |
ROA % |
-111.89 | -116.68 | -86.79 | -48.33 | -19.82 | -22.39 | -28.57 | -19.07 | -24.72 | -17.06 | -21.38 | -15.37 | -13.56 | -12.89 | -7.85 | -11.97 | -12.89 | -14.93 | -18.81 | -16.70 | -14.77 | -11.57 | -12.98 | -15.11 | -16.65 | -19.03 | -20.56 | -28.26 | -40.74 | -45.38 | -45.74 | -37.98 | -26.73 | -18.74 | -14.06 | -12.91 | -10.20 | -10.86 | -14.87 | -16.13 | -17.13 | -18.90 | -17.34 | -19.99 | -23.06 | -26.98 | -30.04 | -33.97 | -38.77 | -40.93 | -10.94 | -11.75 | -10.97 |
ROCE % |
-261.13 | -282.92 | -144.14 | -83.03 | -44.51 | -45.66 | -57.58 | -51.76 | -48.32 | -32.71 | -33.45 | -22.26 | -18.94 | -17.29 | -24.05 | -30.07 | -30.20 | -24.66 | -29.09 | -26.76 | -24.23 | -15.38 | -22.32 | -24.83 | -26.40 | -22.67 | -36.77 | -43.94 | -56.85 | -46.06 | -52.65 | -45.14 | -31.81 | -16.20 | -19.91 | -17.02 | -14.05 | -10.80 | -15.86 | -17.21 | -18.30 | -15.23 | -24.17 | -28.05 | -32.41 | -29.01 | -40.96 | -43.97 | -47.95 | -36.76 | -11.95 | -12.83 | -11.98 |
Current Ratio |
1.5 | 1.3 | 2.6 | 3.6 | 4.2 | 2.1 | 2.1 | - | 2.0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 3.1 | 3.1 | 3.1 | 3.1 | 2.6 | 2.6 | 2.6 | 2.6 | 2.9 | 2.9 | 2.9 | 2.9 | 7.3 | 7.3 | 7.3 | 7.3 | 8.8 | 8.8 | 8.8 | 8.8 | 6.7 | 6.7 | 6.7 | 6.7 | 7.4 | 7.4 | 7.4 | 7.4 | 4.7 | 4.7 | 4.7 | 4.7 | 12.1 | 12.1 | 12.1 | 12.1 |
DSO |
10.2 | 221.6 | 18.8 | 65.0 | 3.1 | - | 7.8 | 10.8 | 20.9 | - | 23.7 | 22.3 | 20.8 | 18.5 | 8.2 | 22.1 | 147.0 | 61.4 | 153.4 | 191.9 | 235.1 | 15.9 | 18.1 | 19.9 | 28.9 | 23.3 | 25.8 | 37.0 | 110.8 | 50.9 | 160.7 | 122.5 | 86.7 | 25.2 | 26.9 | 27.5 | 43.6 | 63.3 | 76.2 | 91.1 | 76.0 | 41.9 | 50.5 | 41.5 | 71.9 | 42.2 | 76.8 | 82.4 | 71.0 | 17.7 | 45.2 | 55.4 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
10.2 | 221.6 | 18.8 | 65.0 | 3.1 | - | 7.8 | 10.8 | 20.9 | - | 23.7 | 22.3 | 20.8 | 18.5 | 8.2 | 22.1 | 147.0 | 61.4 | 153.4 | 191.9 | 235.1 | 15.9 | 18.1 | 19.9 | 28.9 | 23.3 | 25.8 | 37.0 | 110.8 | 50.9 | 160.7 | 122.5 | 86.7 | 25.2 | 26.9 | 27.5 | 43.6 | 63.3 | 76.2 | 91.1 | 76.0 | 41.9 | 50.5 | 41.5 | 71.9 | 42.2 | 76.8 | 82.4 | 71.0 | 17.7 | 45.2 | 55.4 | - |
Cash Conversion Cycle |
10.2 | 221.6 | 18.8 | 65.0 | 3.1 | - | 7.8 | 10.8 | 20.9 | - | 23.7 | 22.3 | 20.8 | 18.5 | 8.2 | 22.1 | 147.0 | 61.4 | 153.4 | 191.9 | 235.1 | 15.9 | 18.1 | 19.9 | 28.9 | 23.3 | 25.8 | 37.0 | 110.8 | 50.9 | 160.7 | 122.5 | 86.7 | 25.2 | 26.9 | 27.5 | 43.6 | 63.3 | 76.2 | 91.1 | 76.0 | 41.9 | 50.5 | 41.5 | 71.9 | 42.2 | 76.8 | 82.4 | 71.0 | 17.7 | 45.2 | 55.4 | - |
All numbers in USD currency